Can a psoriasis drug heal these stubborn skin ulcers?
NCT ID NCT06563323
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests guselkumab (Tremfya), a drug already used for psoriasis, in 17 adults with pyoderma gangrenosum—a rare disease that leads to painful, hard-to-heal skin ulcers. Participants receive injections every 4 weeks for 28 weeks. Researchers will check if ulcers heal completely by week 32, and also track improvement at earlier time points.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- guselkumab (Tremfya)
- What this could lead to
- If successful, this could provide a new treatment option for pyoderma gangrenosum, helping heal painful skin ulcers and reducing the need for steroids.
- What could go wrong
- This is a small, early-phase trial with only 17 participants, so results may not apply to everyone. The drug may not work for all patients, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PYODERMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ohio State Dermatology
RECRUITINGColumbus, Ohio, 43215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Oregon Health and Science University
NOT_YET_RECRUITINGPortland, Oregon, 97239, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene therapy gel targets rare blistering skin disease
- Emergency wound study aims to predict which stitches will fail
- Smartphone app could let diabetic foot ulcer patients skip clinic visits for wound checks
- Gum healing boost? scientists test hyaluronic acid and polynucleotides
- Could a Placenta-Derived powder revolutionize wound healing after skin cancer surgery?
- New hope for bedsores: 2,000-Patient trial tests advanced wound matrices